Back
Mitek Systems, Inc. Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Sell
50
MITK
Mitek Systems, Inc.
Last Price:
$9.15
Seasonality Move:
15.85%
Sell
50
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$68.58
Seasonality Move:
40.49%
Sell
50
Mitek Systems, Inc. (MITK)
is a Sell
Is Mitek Systems, Inc. a Buy, Sell or Hold?
-
The current Mitek Systems, Inc. [MITK] share price is $9.14. The Score for MITK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
MITK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $68.60. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MITK Stock Price Chart
What is Mitek Systems, Inc.'s stock price today?
-
The Mitek Systems, Inc. share price today is $9.14The current trend is relatively stagnant and MITK is experiencing selling pressure, which indicates risk of future bearish movement.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $68.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.
MITK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 50.46 | Buy |
| Chaikin Money Flow: | -278222 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.83 - 9.29) | Buy |
| Bollinger Bands (100): | (9.05 - 10.01) | Sell |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.94 | Buy |
| Relative Strength Index (14 RSI): | 75.92 | Buy |
| Chaikin Money Flow: | 249389 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.15 - 56.87) | Buy |
| Bollinger Bands (100): | (20.01 - 44.73) | Buy |
MITK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.09 | Buy |
| 20-day SMA: | 9.03 | Buy |
| 50-day SMA: | 9.24 | Sell |
| 200-day SMA: | 9.32 | Sell |
| 8-day EMA: | 9.13 | Buy |
| 20-day EMA: | 9.1 | Buy |
| 50-day EMA: | 9.25 | Sell |
| 200-day EMA: | 9.52 | Sell |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.55 | Buy |
| 20-day SMA: | 48.94 | Buy |
| 50-day SMA: | 42.23 | Buy |
| 200-day SMA: | 23.8 | Buy |
| 8-day EMA: | 60.08 | Buy |
| 20-day EMA: | 52.14 | Buy |
| 50-day EMA: | 43.49 | Buy |
| 200-day EMA: | 29.21 | Buy |
Mitek Systems, Inc. Earnings Growth & MITK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.18 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.
Mitek Systems, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||